(Waltham, MA, Friday, September 2, 2016) â€“ September is Ovarian Cancer Awareness Month. An estimated one in 75 women will develop ovarian cancer during her lifetime. The American Cancer Society estimates that there will be more than 22,000 new cases of ovarian cancer diagnosed this year in the United States, and more than 14,000 women will die from this disease in 2016. 
An oncology-focused biopharmaceutical company headquartered in Waltham, TESARO, is partnering with the National Ovarian Cancer Coalition (or NOCC) to support their annual Run/Walk to Break the Silence on Ovarian Cancer. This event is hosted annually by more than 25 chapters nationwide, including South Boston on Sunday, September 11 and Nashua, New Hampshire on Sunday, September 18.
Anne Sweeney, Massachusetts Chapter Manager of NOCC, discusses raising awareness for ovarian cancer and the upcoming walk.
OUR MISSION IS TO SAVE LIVES BY FIGHTING TIRELESSLY TO PREVENT AND CURE OVARIAN CANCER, AND TO IMPROVE THE QUALITY OF LIFE FOR SURVIVORS. THE GOAL OF OUR WALK IS TO SPREAD AWARENESS, CELEBRATE THOSE SURVIVING AND THRIVING, AND HONOR THOSE WE HAVE LOST TO THE DISEASE. WE ARE EXCITED ABOUT THIS PARTNERSHIP TO INCREASE AWARENESS OF OVARIAN CANCER.
Lonnie Moulder, CEO of TESARO, explains their commitment to women living with ovarian cancer.
WITH OUR TEAM OF APPROXIMATELY FOUR HUNDRED PASSIONATE ASSOCIATES, WE ARE DEDICATED TO IMPROVING THE TREATMENT OPTIONS AVAILABLE TO PATIENTS. PLEASE JOIN US AS WE WALK TO PROVIDE HOPE TO THE WOMEN, FAMILIES AND COMMUNITIES TOUCHED BY OVARIAN CANCER.
Race details and information can be found at ovarian.org.
 â€śWhat are the key statistics about ovarian cancer?â€ť American Cancer Society, 4 Feb. 2016, http://www.cancer.org/cancer/ovariancancer/detailedguide/ovarian-cancer-key-statistics